Table 2.
Instrument or subscore (reference range) | Mean±SD | Range | Inter-observer reliability (ICC) | Intra-observer or test-retest reliability (ICC) | Cronbach’s alpha |
---|---|---|---|---|---|
iscorEB clinician (0–114) | 11.3±10.9 | 0–47.1 | 0.96 | 0.89 | |
Skin (0–60) | 4.1±5.4 | 0–26.1 | 0.88 | 0.91 | 0.85 |
Mucosal (0–20) | 3.2±2.0 | 0–8 | 0.82 | 0.70 | 0.88 |
Internal organ (0–12) | 1.6±1.7 | 0–7 | 0.97 | 0.88 | |
Laboratory abnormalities (0–11) | 1.5±2.1 | 0–7 | 0.98 | 0.86 | |
Complications / procedures (0–11) | 0.9±1.4 | 0–5 | 0.91 | 0.88 | |
BEBS (0–100) | 13.4±14.3 | 0–59 | 0.96 | 0.89 | |
iscorEB patient (0–120) |
32.4±16.2 | 0–70 | - | 0.97 | 0.84 |
QOLEB (0–75), N=15 | 16.3±8.8 | 2–33 | - | 0.91 | |
CDLQI (0–30), N=15 | 11.4±4.9 | 2–20 | - | 0.67 |
SD-standard deviation
BEBS- Epidermolysis Bullosa Severity score
QOLEB- Quality of Life Epidermolysis Bullosa
CDLQI- Childhood Dermatology Life Quality Index